ANGPT2 and B-cell chronic lymphocytic leukemia: Considering that normal B cells showed high levels of ANGPT2 methylation, the apparently aberrant low ANGPT2 methylation levels found in aggressive CLL patients indicate that these latter cases lose normal epigenetic control [14, 119–121].